Stumpf, Sina K.
Berghoff, Stefan A.
Trevisiol, Andrea
Spieth, Lena
Düking, Tim
Schneider, Lennart V.
Schlaphoff, Lennart
Dreha-Kulaczewski, Steffi
Bley, Annette
Burfeind, Dinah
Kusch, Kathrin
Mitkovski, Miso
Ruhwedel, Torben
Guder, Philipp
Röhse, Heiko
Denecke, Jonas
Gärtner, Jutta
Möbius, Wiebke
Nave, Klaus-Armin
Saher, Gesine http://orcid.org/0000-0003-3507-9604
Article History
Received: 11 December 2018
Revised: 25 February 2019
Accepted: 1 March 2019
First Online: 27 March 2019
Change Date: 3 September 2019
Change Type: Correction
Change Details: The original article was published
Compliance with ethical standards
:
: The authors have nothing to declare.
: All animal studies were performed in compliance with the animal policies of the Max Planck Institute of Experimental Medicine, and were approved by the German Federal State of Lower Saxony.
: The cholesterol supplementation in PMD patients was started as an individual trial following the general guidelines and ethical standards established by the Universities Medicine Göttingen and Hamburg. Research based MRI studies were approved by the local Ethics Committees of the Universities Medicine Gttingen and Hamburg. Informed consents were obtained from the parents.